References
- Drüeke T, Witko-Sarsat V, Massy Z, et al. Iron therapy, advanced oxidation protein products and carotid artery intima-media thickness in end-stage renal disease. Circulation. 2002;106:2212–2217. doi:10.1161/01.cir.0000035250.66458.67.
- Anraku M, Kitamura K, Shintomo R, et al. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study. Clin Biochemy. 2008;41:1168–1174. doi:10.1016/j.clinbiochem.2008.07.007. doi: 10.1016/j.clinbiochem.2008.07.007
- Maruyama Y, Nakayama M, Yoshimura K, et al. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels. Nephrol Dial Transplant. 2007;22:1407–1412. doi:10.1093/ndt/gfl789.
- Ganz T. Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Heamatol. 2006;108:1381–1387. doi:10.1016/j.beha.2004.08.020.
- Ali MAM, Luxton AW, Walker WHC. Serum ferritin concentration and bone marrow iron stores: aprospective study. Can Med Assoc J. 1978;118:945–946. PMID: 647567.
- Mast AE, Blinder MA, Gronowski AM, et al. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998;44:45–51. PMID: 9550557 doi: 10.1093/clinchem/44.1.45
- KDOQI, National Kidney Foundation . K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006;47(Suppl. 3):S58–S70. doi:10.1053/j.ajkd.2006.03.010.
- Locatelli F, Bárány P, Covic A, et al. Kidney disease: improving global outcomes guidelines on anemia management in chronic kidney disease: a European renal best practice position statement. Nephrol Dial Transplant. 2013;28:1346–1359. doi:10.1093/ndt/gft033.
- Yamamoto H, Nishi S, Tomo T, et al. 2015 Japanese society for dialysis therapy: guidelines for renal anemia in chronic kidney disease. Renal Replacement Therapy. 2017;3:36), doi:10.1371/journal.pone.0179608 doi: 10.1186/s41100-017-0114-y
- Tsuchiya K, Okano H, Teramura M, et al. Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients. Clin Nephrol. 2003;59:115–123. doi:10.5414/cnp59115.
- Kim JM, Ihm CH, Kim HJ. Evaluation of reticulocyte hemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in hemodialysis patients. Int J Lab Hematol. 2008;30:46–52. doi:10.1111/j.1751-553X doi: 10.1111/j.1751-553X.2007.00904.x
- Mitsuiki K, Harada A, Miyata Y. Assessment of iron deficiency in chronic hemodialysis patients: investigation of cutoff values for reticulocyte hemoglobin content. Clin Exp Nephrol. 2003;7:52–57. doi:10.1007/s101570300007.
- Ogawa C, Tsuchiya K, Tomosugi N, et al. Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study. Plos One. 2017;29:e0179608), doi:10.1371/journal.pone.0179608.
- Tomosugi N, Kawabata H, Wakatabe R, et al. Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. Blood. 2006;108:1381–1387. doi:10.1182/blood-2005-10-4043.
- Vos FE, Schollum JB, Coulter CV, et al. Red blood cell survival in long-term dialysis patients. Am J Kidney Dis. 2011;58:591–598. doi:10.1053/j.ajkd.2011.03.031.
- Brugnara C, Hipp MJ, Irving PJ, et al. Automated reticulocyte counting and measurement of reticulocyte cellular indices. Evaluation of the Miles H*3 blood analyzer. Am J Clin Pathol. 1994;102:623–632. doi:10.1093/ajcp/102.5.623.
- Van Wyck DB, Alcorn H Jr, Gupta R. Analytical and biological variation in measures of anemia and iron status in patients treated with maintenance hemodialysis. Am J Kidney Dis. 2010;56:540–546. doi : 10.1053/j.ajkd.2010.05.009.
- Fishbane S, Shapiro W, Dutka P, et al. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int. 2001;60:2406–2411. doi:10.1046/j.1523-1755.2001.00077.x.
- Tessitore N, Solero GP, Lippi G, et al. The role of iron status markers in predicting response to intravenous iron in hemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant. 2001;16:1416–1423. doi:10.1093/ndt/16.7.1416 .
- Fishbane S, Galgano C, Langley RC Jr, et al. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int. 1997;52:217–222. doi:10.1038/ki.1997.323 .